Pancreas Cancer Survival in the Gemcitabine Era

After multiple positive studies, gemcitabine, approved for the treatment of pancreas cancer by the FDA in 1977, became standard of care. Whether this therapeutic advance has translated into longer survival for pancreas cancer patients in general has not been established. This study, derived from SEE...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wachtel, Mitchell S., Xu, K. Tom, Zhang, Yan, Chiriva-Internati, Maurizio, Frezza, Eldo E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Libertas Academica 2008
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3161658/
https://ncbi.nlm.nih.gov/pubmed/21892307
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi